德曲妥珠单抗临床管理路径及不良反应 处理中国专家共识（2024版).
- Published in:
- Chinese Journal of Oncology, 2024, v. 46, n. 4, p. 304, doi. 10.3760/cma.j.cn112152-20231122-00319
- By:
- Publication type:
- Article
Works by 殷咏梅
Results: 6
1
2
哌柏西利治疗激素受体阳性晚期乳腺癌的 真实世界研究及疗效预测模型.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 4, p. 348, doi. 10.3760/cma.j.cn112152-20210811-00606
- By:
- Publication type:
- Article
3
紫杉醇脂质体在晚期乳腺癌中应用的 真实世界研究.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 1, p. 88, doi. 10.3760/cma.j.cn112152-20200622-00069
- By:
- Publication type:
- Article
4
伊尼妥单抗联合方案在HER2阳性转移性乳腺癌中的疗效与安 全性.
- Published in:
- Journal of Nanjing Medical University: Natural Sciences, 2023, v. 43, n. 12, p. 1675, doi. 10.7655/NYDXBNS20231209
- By:
- Publication type:
- Article
5
LNCRNA FAR2P1 对乳腺癌细胞增殖迁移和凋亡的影响研究.
- Published in:
- Progress in Modern Biomedicine, 2023, v. 23, n. 5, p. 801, doi. 10.13241/j.cnki.pmb.2023.05.001
- By:
- Publication type:
- Article
6
EGFR基因突变状态与晚期肺腺癌一线化疗疗效的相关性.
- Published in:
- Practical Pharmacy & Clinical Remedies, 2017, v. 20, n. 8, p. 883, doi. 10.14053/j.cnki.ppcr.201708006
- By:
- Publication type:
- Article